Mutual of America Capital Management LLC Lowers Position in Agilent Technologies, Inc. (NYSE:A)

Mutual of America Capital Management LLC trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 0.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 50,146 shares of the medical research company’s stock after selling 368 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Agilent Technologies were worth $6,500,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the business. Gilbert & Cook Inc. raised its position in Agilent Technologies by 12.5% during the fourth quarter. Gilbert & Cook Inc. now owns 2,872 shares of the medical research company’s stock valued at $399,000 after purchasing an additional 320 shares in the last quarter. Avantax Advisory Services Inc. grew its holdings in shares of Agilent Technologies by 11.0% during the 4th quarter. Avantax Advisory Services Inc. now owns 2,708 shares of the medical research company’s stock valued at $377,000 after purchasing an additional 268 shares during the last quarter. UBS Group AG raised its position in Agilent Technologies by 84.5% in the 4th quarter. UBS Group AG now owns 325,695 shares of the medical research company’s stock worth $45,281,000 after purchasing an additional 149,159 shares during the period. Coldstream Capital Management Inc. lifted its stake in Agilent Technologies by 55.2% in the fourth quarter. Coldstream Capital Management Inc. now owns 5,574 shares of the medical research company’s stock worth $775,000 after purchasing an additional 1,982 shares during the last quarter. Finally, Thoroughbred Financial Services LLC purchased a new stake in Agilent Technologies during the fourth quarter valued at about $200,000. 87.42% of the stock is currently owned by institutional investors.

Insider Transactions at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.33% of the stock is owned by insiders.

Agilent Technologies Stock Up 2.1 %

Shares of Agilent Technologies stock opened at $141.95 on Friday. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $155.35. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The company has a 50-day moving average of $137.72 and a 200 day moving average of $139.27. The firm has a market cap of $41.42 billion, a price-to-earnings ratio of 33.56, a PEG ratio of 6.43 and a beta of 1.05.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.06. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The business’s revenue was down 5.6% on a year-over-year basis. During the same period last year, the business earned $1.43 earnings per share. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st will be issued a dividend of $0.236 per share. The ex-dividend date is Tuesday, October 1st. This represents a $0.94 annualized dividend and a dividend yield of 0.67%. Agilent Technologies’s payout ratio is presently 22.22%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on A shares. Citigroup boosted their target price on Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Barclays raised their target price on shares of Agilent Technologies from $125.00 to $135.00 and gave the stock an “underweight” rating in a report on Friday, August 23rd. UBS Group upped their price target on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. JPMorgan Chase & Co. cut their price target on shares of Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating on the stock in a report on Thursday, May 30th. Finally, Robert W. Baird cut their target price on Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating on the stock in a research note on Thursday, May 30th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $141.60.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.